Dr. Jonathan Schoenfeld discusses the need for collaboration among teams when a patient is receiving a combination of immunotherapy and radiation treatment.
Jonathan Schoenfeld, MD, MPhil, MPH, of Dana-Farber Cancer Institute, talks about the collaboration between teams for patients who are receiving combination therapies.
When it comes to a combined treatment plan of radiation and immunotherapy, both radiation and medical oncologists must be involved. Additionally, with the potential of immune-related adverse events, Schoenfeld suggests the inclusion of gastroenterologists, dermatologists, and endocrinologists.
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis
Improvements in Health Systems Model Reduces Disparities in Leukemia Survival in Low-Income Countries
Telephone and Web-Based Program Elicits Clinically Meaningful Results in Breast Cancer Survivors
Luspatercept Elicits High Transfusion Independence Rates in Lower-Risk MDS
2 Clarke Drive
Cranbury, NJ 08512